Results 81 to 90 of about 4,614 (205)
International Journal of Nanomedicine, 2023 Jianmeng Zhu,1,* Yimin Yang,2,3,* Jian Wang,1 Wenzhong Hong,1 Yiping Li,1 Zhen Wang,2 Kaiqiang Li2 1Clinical Laboratory of Chun’an First People’s Hospital, Zhejiang Provincial People’s Hospital Chun’an Branch, Hangzhou, Zhejiang, People’s ...
Zhu J +6 more
doaj
Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents
Chemistry – A European Journal, Volume 32, Issue 17, 5 May 2026.This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley +1 more source
Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction
Advanced Healthcare Materials, Volume 15, Issue 20, 27 May 2026.Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang +4 more
wiley +1 more source
Pharmaceutics, 2020 Background: Paclitaxel (PTX) is a widely used anti-cancer drug for treating various types of solid malignant tumors including breast, ovarian and lung cancers. However, PTX has a low therapeutic response and is linked with acquired resistance, as well as
Farah Rehan +5 more
doaj +1 more source
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.This meta‐analysis of trials was conducted to assess the effect of nanocurcumin supplementation in type 2 diabetes mellitus. ABSTRACT Background Nanocurcumin has been developed to overcome the poor bioavailability of conventional curcumin and has been proposed as a potential adjunctive therapy for type 2 diabetes mellitus (T2DM).
Sahar Ghoflchi +5 more
wiley +1 more source
, 2021 Cutaneous leishmaniasis is known as the most prevalent clinical form of leishmaniasis. It needs the development of new therapies due to the serious side-effects promoted by taking the current drugs.
Asadi, P. +4 more
core +1 more source
New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles
Molecules, 2016 Intravenous administration of Taxotere® (a commercial form of docetaxel, DTX) leads to many problems such as hypersensitivity, hemolysis, cutaneous allergy, and patient refusal due to its prolonged injection. The oral absorption of DTX is very low due to
Atefeh Hekmat +4 more
doaj +1 more source
Recent progress on stimuli‐responsive chitosan‐based biomaterials as drug carriers
Interdisciplinary Medicine, Volume 4, Issue 3, May 2026.This review discusses the recent progress in chitosan‐based drug delivery systems that respond to pH, redox, enzymes, reactive oxygen species, and combined stimuli. It examines design strategies, key mechanisms, and therapeutic applications, and also addresses current challenges while suggesting future approaches to enhance clinical translation and ...
Changlu Xu +4 more
wiley +1 more source
Size characterization and initial effects of CTZ-containing nanomicelles.
, 2015 Nanomicelles were prepared as described in Materials and Methods in the presence or absence of CTZ. The size of the nanomicelles was analyzed by dynamic light scattering as described above. Panel A: nanomicelles prepared in the absence of CTZ.
Ivaldo Itabaiana Jr. (758871) +5 more
core +1 more source
pH-Responsive Lignin-Based Nanomicelles for Oral Drug Delivery
, 2020 A pH-stimuli amphiphilic lignin-based copolymer was prepared, and it could self-assemble to form spherical nanomicelles with the addition of “switching” water.
Shaofei Nie (8752473) +10 more
core +1 more source